View in EDS

Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774: dynamics of receptor inhibition in situ and antitumor effects in athymic mice.

Saved in:
Bibliographic Details
Title: Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774: dynamics of receptor inhibition in situ and antitumor effects in athymic mice.
Authors: Pollack VA; Department of Genomics, Targets and Cancer Research, Pfizer Central Research, Groton, Connecticut 06340, USA. vincent_a_pollack@groton.pfizer.com, Savage DM, Baker DA, Tsaparikos KE, Sloan DE, Moyer JD, Barbacci EG, Pustilnik LR, Smolarek TA, Davis JA, Vaidya MP, Arnold LD, Doty JL, Iwata KK, Morin MJ
Source: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 1999 Nov; Vol. 291 (2), pp. 739-48.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0376362 Publication Model: Print Cited Medium: Print ISSN: 0022-3565 (Print) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 10525095
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774: dynamics of receptor inhibition in situ and antitumor effects in athymic mice.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pollack+VA%22">Pollack VA</searchLink>; Department of Genomics, Targets and Cancer Research, Pfizer Central Research, Groton, Connecticut 06340, USA. vincent_a_pollack@groton.pfizer.com<br /><searchLink fieldCode="AU" term="%22Savage+DM%22">Savage DM</searchLink><br /><searchLink fieldCode="AU" term="%22Baker+DA%22">Baker DA</searchLink><br /><searchLink fieldCode="AU" term="%22Tsaparikos+KE%22">Tsaparikos KE</searchLink><br /><searchLink fieldCode="AU" term="%22Sloan+DE%22">Sloan DE</searchLink><br /><searchLink fieldCode="AU" term="%22Moyer+JD%22">Moyer JD</searchLink><br /><searchLink fieldCode="AU" term="%22Barbacci+EG%22">Barbacci EG</searchLink><br /><searchLink fieldCode="AU" term="%22Pustilnik+LR%22">Pustilnik LR</searchLink><br /><searchLink fieldCode="AU" term="%22Smolarek+TA%22">Smolarek TA</searchLink><br /><searchLink fieldCode="AU" term="%22Davis+JA%22">Davis JA</searchLink><br /><searchLink fieldCode="AU" term="%22Vaidya+MP%22">Vaidya MP</searchLink><br /><searchLink fieldCode="AU" term="%22Arnold+LD%22">Arnold LD</searchLink><br /><searchLink fieldCode="AU" term="%22Doty+JL%22">Doty JL</searchLink><br /><searchLink fieldCode="AU" term="%22Iwata+KK%22">Iwata KK</searchLink><br /><searchLink fieldCode="AU" term="%22Morin+MJ%22">Morin MJ</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220376362%22">The Journal of pharmacology and experimental therapeutics</searchLink> [J Pharmacol Exp Ther] 1999 Nov; Vol. 291 (2), pp. 739-48.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>0376362 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0022-3565 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200223565%22">00223565 </searchLink><i>NLM ISO Abbreviation: </i>J Pharmacol Exp Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=10525095
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 739
    Titles:
      – TitleFull: Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774: dynamics of receptor inhibition in situ and antitumor effects in athymic mice.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pollack VA
      – PersonEntity:
          Name:
            NameFull: Savage DM
      – PersonEntity:
          Name:
            NameFull: Baker DA
      – PersonEntity:
          Name:
            NameFull: Tsaparikos KE
      – PersonEntity:
          Name:
            NameFull: Sloan DE
      – PersonEntity:
          Name:
            NameFull: Moyer JD
      – PersonEntity:
          Name:
            NameFull: Barbacci EG
      – PersonEntity:
          Name:
            NameFull: Pustilnik LR
      – PersonEntity:
          Name:
            NameFull: Smolarek TA
      – PersonEntity:
          Name:
            NameFull: Davis JA
      – PersonEntity:
          Name:
            NameFull: Vaidya MP
      – PersonEntity:
          Name:
            NameFull: Arnold LD
      – PersonEntity:
          Name:
            NameFull: Doty JL
      – PersonEntity:
          Name:
            NameFull: Iwata KK
      – PersonEntity:
          Name:
            NameFull: Morin MJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 1999 Nov
              Type: published
              Y: 1999
          Identifiers:
            – Type: issn-print
              Value: 0022-3565
          Numbering:
            – Type: volume
              Value: 291
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: The Journal of pharmacology and experimental therapeutics
              Type: main
ResultId 1